Literature DB >> 29423295

TRPA1 polymorphisms in chronic and complete spinal cord injury patients with neuropathic pain: a pilot study.

Sonia Vidal Rodriguez1, Inmaculada Castillo Aguilar2, Luis Cuesta Villa3, Francisco Serrano Saenz de Tejada3.   

Abstract

STUDY
DESIGN: Pilot study.
OBJECTIVES: Single-nucleotide polymorphisms (SNPs) in TRPA1 gene are related to the etiology of chronic pain. The study is a pilot study with the primary objective of analyzing these SNPs in Spanish patients with chronic and complete spinal cord injury (SCI) and neuropathic pain (NPP).
SETTING: Asepeyo Hospital Department of Chronic and Complete SCI.
METHODS: Twelve patients with chronic and complete SCI and NPP, and 12 patients with chronic and complete SCI with no pain were reviewed. International Spinal Cord Injury Pain Classification (LANSS) and visual analog score (VAS) were chosen to classify pain syndrome. SNPs were identified by melting analysis after DNA amplification with real-time fluorescence PCR.
RESULTS: There were differences in rs11988795 variant: GG homozygous (p = 0.01) and G allele (p = 0.001) were more frequent in SCI patients with no pain. There were differences in rs13255063 variant: TT homozygous were prevalent (p = 0.03) in patients with NPP.
CONCLUSIONS: Until now this is the first study to show a description of TRPA1 SNPs in Spanish patients with chronic and complete SCI and NPP. These results suggest that GG genotype in rs11988795 variant and G allele could be protective factors against NPP. TT genotype in rs13255063 variant could be a risk factor for NPP. Neuropathic pain after spinal cord injuries may have genetic contributions.

Entities:  

Year:  2017        PMID: 29423295      PMCID: PMC5798909          DOI: 10.1038/s41394-017-0004-0

Source DB:  PubMed          Journal:  Spinal Cord Ser Cases        ISSN: 2058-6124


  52 in total

Review 1.  Transient receptor potential genes and human inherited disease.

Authors:  Kate V Everett
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

Review 2.  Transient receptor potential channels as therapeutic targets.

Authors:  Magdalene M Moran; Michael Allen McAlexander; Tamás Bíró; Arpad Szallasi
Journal:  Nat Rev Drug Discov       Date:  2011-08-01       Impact factor: 84.694

3.  Antinociceptive activity of transient receptor potential channel TRPV1, TRPA1, and TRPM8 antagonists in neurogenic and neuropathic pain models in mice.

Authors:  Kinga Sałat; Barbara Filipek
Journal:  J Zhejiang Univ Sci B       Date:  2015-03       Impact factor: 3.066

4.  TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Δ(9)-tetrahydrocannabiorcol.

Authors:  David A Andersson; Clive Gentry; Lisa Alenmyr; Dan Killander; Simon E Lewis; Anders Andersson; Bernard Bucher; Jean-Luc Galzi; Olov Sterner; Stuart Bevan; Edward D Högestätt; Peter M Zygmunt
Journal:  Nat Commun       Date:  2011-11-22       Impact factor: 14.919

5.  TRPA1 contributes to cold hypersensitivity.

Authors:  Donato del Camino; Sarah Murphy; Melissa Heiry; Lee B Barrett; Taryn J Earley; Colby A Cook; Matt J Petrus; Michael Zhao; Marc D'Amours; Nate Deering; Gary J Brenner; Michael Costigan; Neil J Hayward; Jayhong A Chong; Christopher M Fanger; Clifford J Woolf; Ardem Patapoutian; Magdalene M Moran
Journal:  J Neurosci       Date:  2010-11-10       Impact factor: 6.167

6.  Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury.

Authors:  Funda Levendoglu; Cemile O Ogün; Onder Ozerbil; Tunç C Ogün; Hatice Ugurlu
Journal:  Spine (Phila Pa 1976)       Date:  2004-04-01       Impact factor: 3.468

7.  Dissociated modulation of conditioned place-preference and mechanical hypersensitivity by a TRPA1 channel antagonist in peripheral neuropathy.

Authors:  Hong Wei; Hanna Viisanen; Diana Amorim; Ari Koivisto; Antti Pertovaara
Journal:  Pharmacol Biochem Behav       Date:  2012-12-31       Impact factor: 3.533

Review 8.  Systematic Review of Pharmacologic Treatments of Pain After Spinal Cord Injury: An Update.

Authors:  Swati Mehta; Amanda McIntyre; Shannon Janzen; Eldon Loh; Robert Teasell
Journal:  Arch Phys Med Rehabil       Date:  2016-01-12       Impact factor: 3.966

Review 9.  Emerging targets in neuroinflammation-driven chronic pain.

Authors:  Ru-Rong Ji; Zhen-Zhong Xu; Yong-Jing Gao
Journal:  Nat Rev Drug Discov       Date:  2014-06-20       Impact factor: 84.694

10.  Health-related quality of life among individuals with long-standing spinal cord injury: a comparative study of veterans and non-veterans.

Authors:  Soheil Saadat; Masoud Javadi; Baharak Sabet Divshali; Amir Hussein Tavakoli; Seyed Mohammad Ghodsi; Ali Montazeri; Vafa Rahimi-Movaghar
Journal:  BMC Public Health       Date:  2010-01-05       Impact factor: 3.295

View more
  2 in total

1.  Psychological and Genetic Predictors of Pain Tolerance.

Authors:  Asad E Patanwala; Charles Norwood; Heidi Steiner; Daniel Morrison; May Li; Keith Walsh; Marina Martinez; Sarah E Baker; Eric M Snyder; Jason H Karnes
Journal:  Clin Transl Sci       Date:  2018-12-31       Impact factor: 4.689

2.  A pilot study of neuromuscular electrical stimulation for neuropathic pain caused by spinal cord injury.

Authors:  Fu-Chun Chen; Hai-Long Shao; Feng-Li Han
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.